American Association for Cancer Research 98th Annual Meeting. Anticancer agents - Part II.
Filson
Sarah
S
Thomson Scientific, The Johnson Building, 77 Hatton Garden, London, EC1N 8JS, UK. sarah.filson@thomson.com
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004353:Drug Evaluation, Preclinical; D006801:Humans; D009369:Neoplasms / Q000098:blood supply / Q000188:drug therapy*; D012106:Research; D059004:Topoisomerase I Inhibitors
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D059004:Topoisomerase I Inhibitors